{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:22:34Z","timestamp":1774876954109,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.transproceed.2024.03.043","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T11:45:26Z","timestamp":1720439126000},"page":"1469-1477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bexarotene Induce Differentiation of Myeloid-Derived Suppressor Cells through Arg-1 Signalling Pathway"],"prefix":"10.1016","volume":"56","author":[{"given":"Haozhou","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoguang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.transproceed.2024.03.043_bib0001","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3727\/096368910X540621","article-title":"In vivo induction of myeloid suppressor cells and CD4(+)Foxp3(+) T regulatory cells prolongs skin allograft survival in mice","volume":"20","author":"Adeegbe","year":"2011","journal-title":"Cell Transplant"},{"key":"10.1016\/j.transproceed.2024.03.043_bib0002","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ctrv.2017.10.007","article-title":"Cutaneous T-cell lymphomas: focusing on novel agents in relapsed and refractory disease","volume":"61","author":"Argnani","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.transproceed.2024.03.043_bib0003","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.transproceed.2024.03.043_bib0004","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/S0021-9258(18)71855-3","article-title":"Purification and properties of colony-stimulating factor from mouse lung-conditioned medium","volume":"252","author":"Burgess","year":"1977","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.transproceed.2024.03.043_bib0005","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1001\/jamadermatol.2018.3679","article-title":"Association of APOA5 and APOC3 genetic polymorphisms with severity of hypertriglyceridemia in patients with cutaneous T-cell lymphoma treated with bexarotene","volume":"154","author":"Cabello","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.transproceed.2024.03.043_bib0006","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/STROKEAHA.119.027037","article-title":"Bexarotene enhances macrophage erythrophagocytosis and hematoma clearance in experimental intracerebral hemorrhage","volume":"51","author":"Chang","year":"2020","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.transproceed.2024.03.043_bib0007","doi-asserted-by":"crossref","first-page":"e14123","DOI":"10.1111\/ctr.14123","article-title":"Randomized trial of 3 maintenance regimens (TAC\/SRL vs. TAC\/MMF vs. CSA\/SRL) with low-dose corticosteroids in primary kidney transplantation: 18-year results","volume":"34","author":"Ciancio","year":"2020","journal-title":"Clin Transplant"},{"issue":"6075","key":"10.1016\/j.transproceed.2024.03.043_bib0008","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","article-title":"ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models","volume":"335","author":"Cramer","year":"2012","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.transproceed.2024.03.043_bib0009","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.4049\/jimmunol.180.12.7898","article-title":"Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion","volume":"180","author":"Dugast","year":"2008","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.transproceed.2024.03.043_bib0010","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1600-6143.2006.01645.x","article-title":"Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study","volume":"7","author":"Ekberg","year":"2007","journal-title":"Am J Transplant"},{"issue":"25","key":"10.1016\/j.transproceed.2024.03.043_bib0011","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.transproceed.2024.03.043_bib0012","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/0008-5472.CAN-06-3037","article-title":"The terminology issue for myeloid-derived suppressor cells","volume":"67","author":"Gabrilovich","year":"2007","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.transproceed.2024.03.043_bib0013","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/eji.200939486","article-title":"Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development","volume":"39","author":"Greifenberg","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.transproceed.2024.03.043_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.600000","article-title":"CD86 is a selective CD28 ligand supporting FoxP3+ regulatory T cell homeostasis in the presence of high levels of CTLA-4","volume":"11","author":"Halliday","year":"2020","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.transproceed.2024.03.043_bib0015","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJMra2014530","article-title":"Long-term survival after kidney transplantation","volume":"385","author":"Hariharan","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.transproceed.2024.03.043_bib0016","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","article-title":"Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host","volume":"66","author":"Huang","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.transproceed.2024.03.043_bib0017","article-title":"Myeloid-derived suppressor cells are increased in lung transplant recipients and regulated by immunosuppressive therapy","volume":"12","author":"Iglesias-Escudero","year":"2021","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.transproceed.2024.03.043_bib0018","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/jop.12885","article-title":"Macrophage CCL22 expression in the tumor microenvironment and implications for survival in patients with squamous cell carcinoma of the tongue","volume":"48","author":"Kimura","year":"2019","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.transproceed.2024.03.043_bib0019","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41523-019-0135-5","article-title":"Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer models","volume":"5","author":"Leal","year":"2019","journal-title":"NPJ Breast Cancer"},{"issue":"12","key":"10.1016\/j.transproceed.2024.03.043_bib0020","doi-asserted-by":"crossref","first-page":"16219","DOI":"10.18632\/aging.203152","article-title":"Immunological discrepancy in aged mice facilitates skin allograft survival","volume":"13","author":"Lee","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"9","key":"10.1016\/j.transproceed.2024.03.043_bib0021","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1111\/ajt.15879","article-title":"Myeloid-derived suppressor cells expand after transplantation and their augmentation increases graft survival","volume":"20","author":"Lee","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2024.03.043_bib0022","article-title":"The mTOR deficiency in monocytic myeloid-derived suppressor cells protects mouse cardiac allografts by inducing allograft tolerance","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.transproceed.2024.03.043_bib0023","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.immuni.2010.05.010","article-title":"Tumor-induced tolerance and immune suppression depend on the C\/EBPbeta transcription factor","volume":"32","author":"Marigo","year":"2010","journal-title":"Immunity"},{"issue":"Pt 12","key":"10.1016\/j.transproceed.2024.03.043_bib0024","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1093\/brain\/awv289","article-title":"Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination","volume":"138","author":"Natrajan","year":"2015","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.transproceed.2024.03.043_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/stem.5530050102","article-title":"Granulocyte colony-stimulating factor and differentiation-induction in myeloid leukemic cells","volume":"5","author":"Nicola","year":"1987","journal-title":"Int J Cell Cloning"},{"issue":"3","key":"10.1016\/j.transproceed.2024.03.043_bib0026","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2133.2008.08931.x","article-title":"Bexarotene activates the p53\/p73 pathway in human cutaneous T-cell lymphoma","volume":"160","author":"Nieto-Rementeria","year":"2009","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.transproceed.2024.03.043_bib0027","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.transproceed.2024.03.043_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.631365","article-title":"Adoptive transfer of regulatory immune cells in organ transplantation","volume":"12","author":"Oberholtzer","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.transproceed.2024.03.043_bib0029","doi-asserted-by":"crossref","first-page":"14979","DOI":"10.1038\/ncomms14979","article-title":"Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade","volume":"8","author":"Ouzounova","year":"2017","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.transproceed.2024.03.043_bib0030","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.immuni.2013.02.007","article-title":"Tumor necrosis factor-alpha blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation","volume":"38","author":"Sade-Feldman","year":"2013","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.transproceed.2024.03.043_bib0031","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.intimp.2011.03.010","article-title":"Hematopoietic cytokine-induced transcriptional regulation and Notch signaling as modulators of MDSC expansion","volume":"11","author":"Saleem","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.transproceed.2024.03.043_bib0032","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jconrel.2021.05.033","article-title":"A dual macrophage polarizer conjugate for synergistic melanoma therapy","volume":"335","author":"Sallam","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.transproceed.2024.03.043_bib0033","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3389\/fonc.2019.00907","article-title":"Bexarotene reduces production of CCL22 from tumor-associated macrophages in cutaneous T-cell lymphoma","volume":"9","author":"Tanita","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.transproceed.2024.03.043_bib0034","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12882-015-0078-5","article-title":"mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis","volume":"16","author":"Xie","year":"2015","journal-title":"BMC Nephrol"},{"issue":"8","key":"10.1016\/j.transproceed.2024.03.043_bib0035","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","article-title":"Subsets of myeloid-derived suppressor cells in tumor-bearing mice","volume":"181","author":"Youn","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.transproceed.2024.03.043_bib0036","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fimmu.2020.00269","article-title":"Bone marrow-derived and elicited peritoneal macrophages are not created equal: the questions asked dictate the cell type used","volume":"11","author":"Zajd","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.transproceed.2024.03.043_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104300","article-title":"Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseases","volume":"362","author":"Zhang","year":"2021","journal-title":"Cell Immunol"},{"issue":"2","key":"10.1016\/j.transproceed.2024.03.043_bib0038","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/CIRCULATIONAHA.117.030811","article-title":"Cardioprotective role of myeloid-derived suppressor cells in heart failure","volume":"138","author":"Zhou","year":"2018","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.transproceed.2024.03.043_bib0039","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/iovs.62.7.3","article-title":"Ex vivo-induced bone marrow-derived myeloid suppressor cells prevent corneal allograft rejection in mice","volume":"62","author":"Zhu","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113452400321X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113452400321X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T05:15:06Z","timestamp":1724822106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004113452400321X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S004113452400321X"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.03.043","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bexarotene Induce Differentiation of Myeloid-Derived Suppressor Cells through Arg-1 Signalling Pathway","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.03.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}